Skin and synovium from SLE patients have highly enriched downstream IFN signatures with IFNB1 signatures predominating whereas lupus nephritis kidneys have comparatively lower expression of all downstream IFN signatures. This evidence concerns the gene IFNB1 and systemic lupus erythematosus.